- Home
- CHDN vs CRSP Comparison
CHDN vs CRSP Comparison
Compare CHDN & CRSP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | CHDN | CRSP |
|---|---|---|
| Founded | 1928 | 2013 |
| Country | United States | Switzerland |
| Employees | N/A | N/A |
| Industry | Services-Misc. Amusement & Recreation | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.8B | 5.0B |
| IPO Year | 1995 | 2016 |
Fundamental Metrics
Financial Performance| Metric | CHDN | CRSP |
|---|---|---|
| Price | $82.85 | $49.48 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 9 | 17 |
| Target Price | ★ $138.44 | $70.29 |
| AVG Volume (30 Days) | 978.4K | ★ 1.6M |
| Earning Date | 04-22-2026 | 05-11-2026 |
| Dividend Yield | ★ 0.43% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 5.49 | N/A |
| Revenue | ★ $1,809,800,000.00 | $289,590,000.00 |
| Revenue This Year | $5.75 | $807.72 |
| Revenue Next Year | $3.52 | $172.52 |
| P/E Ratio | $15.36 | ★ N/A |
| Revenue Growth | 13.31 | ★ 9169.85 |
| 52 Week Low | $79.40 | $44.12 |
| 52 Week High | $118.35 | $78.48 |
Technical Indicators
Market Signals| Indicator | CHDN | CRSP |
|---|---|---|
| Relative Strength Index (RSI) | 41.54 | 47.60 |
| Support Level | N/A | $48.54 |
| Resistance Level | $90.25 | $59.83 |
| Average True Range (ATR) | 2.84 | 1.77 |
| MACD | -0.12 | 0.06 |
| Stochastic Oscillator | 23.49 | 65.43 |
Price Performance
Historical ComparisonAbout CHDN Churchill Downs Incorporated
Churchill Downs Inc is a gaming entertainment, online wagering, and racing company. It operates through three business segments: Live and Historical Racing, Wagering Services, and Gaming. The Live and Historical Racing segment includes live and historical pari-mutuel racing. The Wagering Services segment includes the revenue and expenses from pari-mutuel wagers through TwinSpires, companies retail and online sports betting business and Gaming segment includes revenue and expenses for the casino properties and associated racetracks that support the casino license. The Gaming segment generates revenue and expenses from slot machines, video lottery terminals, video poker, HRMs, ancillary food and beverage services, hotel services, commission on pari-mutuel wagering, and racing events.
About CRSP CRISPR Therapeutics AG
Crispr Therapeutics is a gene editing company focused on the development of Crispr/Cas9-based therapeutics. Crispr/Cas9 stands for clustered regularly interspaced short palindromic repeats (Crispr)/Crispr-associated protein 9 (Cas9), which is a revolutionary technology for precisely altering specific sequences of genomic DNA. The company is focused on using this technology to treat genetically defined diseases. Crispr's first approved drug is Casgevy, which was developed in collaboration with Vertex Pharmaceuticals and targets sickle-cell disease and transfusion-dependent beta-thalassemia. The company is advancing a variety of gene editing programs in immuno-oncology, cardiovascular, and a stem cell-derived therapy to treat Type 1 diabetes.